Why do omic foundation models keep failing?
Genomic Foundationless Models: Pretraining Does Not Promise Performance
Deep learning-based predictions of gene perturbation effects do not yet outperform simple linear methods
Foundation models struggle with omic tasks such as gene perturbation prediction and genome representation due to a combination of intrinsic biological complexity and methodological limitations. Here’s a structured breakdown of the key reasons:
Data Challenges:
Sparsity and High Dimensionality: Omic data (e.g., gene expression, epigenetics) often has thousands of features but limited samples, leading to overfitting.
Noise and Variability: Technical artifacts (e.g., batch effects) and biological variability reduce signal-to-noise ratios, complicating model generalization.
Privacy and Accessibility: Sensitive genomic data restricts large-scale data aggregation, limiting training data diversity and volume.
Biological Complexity:
Non-linear Interactions: Gene regulation involves intricate feedback loops, epistasis, and context-dependent interactions that are hard to model.
Multi-modality and Dynamics: Integrating diverse data types (DNA, RNA, proteins) and capturing temporal/spatial dynamics (e.g., cell-state changes) exceeds current model capabilities.
Architectural Limitations:
Sequence Length: Genomes are orders of magnitude longer than text sequences, challenging Transformer-based models with limited context windows.
3D Structure Ignorance: Models often ignore chromatin folding or epigenetic spatial interactions critical for gene regulation.
Learning Paradigms:
Ineffective Self-Supervision: Tasks like masked nucleotide prediction may not capture higher-order biological functions (e.g., gene ontology, pathway interactions).
Task Specificity: Broad pre-training may miss nuances required for specialized tasks (e.g., CRISPR knockout effects).
Evaluation and Interpretability:
Misaligned Metrics: Model performance metrics (e.g., accuracy) may not correlate with biological relevance or clinical utility.
Black-Box Nature: Biologists require mechanistic insights, but foundation models often lack interpretability.
Ethical and Practical Barriers:
Validation Costs: Experimental validation is slow and expensive, hindering iterative model refinement.
Regulatory Hurdles: Compliance with data privacy laws (e.g., GDPR) complicates data sharing and reuse.
Emerging Solutions:
Improved Architectures: Hierarchical or sparse Transformers to handle long sequences; graph neural networks for interaction networks.
Better Pretraining Tasks: Incorporating gene ontology, pathway data, or synthetic data to enhance biological relevance.
Multi-modal Integration: Combining omics with imaging, clinical data, or literature to enrich context.
Active Learning: Prioritizing high-impact experiments to reduce validation costs.